Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01045733 · ClinicalTrials.gov registry record · NA

A Comparison of Corneal Aberrations in Subjects With Contralateral AcrySof IQ Toric Intraocular Lens (IOL) and AcrySof IQ IOL With Limbal Relaxing Incision (LRI)

A NA study of Cataract and Astigmatism, sponsored by Alcon Research.

Completed
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT01045733: Completed NA study of Cataract and Astigmatism, sponsored by Alcon Research.

NCT01045733 is a NA study of Cataract and Astigmatism that has completed, run by Alcon Research. The registered enrollment target is 70 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01045733, a NA study of Cataract and Astigmatism, has completed, sponsored by Alcon Research.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to evaluate and compare postoperative corneal aberrations and visual parameters in patients contralaterally implanted with an AcrySof IQ Toric intraocular lens (IOL) and AcrySof IQ Aspheric IOL with concomitant limbal relaxing incision.

Conditions Studied

Cataract Astigmatism

Interventions

  • DEVICE AcrySof IQ Toric IOL
  • DEVICE AcrySof IQ Aspheric IOL
  • PROCEDURE Limbal Relaxing Incision (LRI)

Study Locations (1)

Texas

  • Contact Alcon Call Center for Trial Locations - Fort Worth

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2009-12
Est. Completion 2011-05
Phase NA
Alcon Research

275 total trials

What the finished NCT01045733 record still lists

NCT01045733 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (69% lower).

The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 3 interventions - of which AcrySof IQ Toric IOL is the first listed.

NCT01045733 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01045733 about?

NCT01045733 is a clinical study titled "A Comparison of Corneal Aberrations in Subjects With Contralateral AcrySof IQ Toric Intraocular Lens (IOL) and AcrySof IQ IOL With Limbal Relaxing Incision (LRI)". The purpose of this study was to evaluate and compare postoperative corneal aberrations and visual parameters in patients contralaterally implanted with an AcrySof IQ Toric intraocular lens (IOL) and AcrySof IQ Aspheric IOL with concomitant limbal relaxing incision.

What is the current status of trial NCT01045733?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2009-12. Estimated completion is 2011-05.

What conditions does trial NCT01045733 study?

This clinical trial studies the following conditions: Cataract, Astigmatism.

What interventions are being tested in trial NCT01045733?

The interventions under investigation include: AcrySof IQ Toric IOL (DEVICE), AcrySof IQ Aspheric IOL (DEVICE), Limbal Relaxing Incision (LRI) (PROCEDURE).

Who is sponsoring clinical trial NCT01045733?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01045733 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cataract

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01045733's enrollment target sits among peer trials

70 48th of 83 higher than 35 of 83 other Cataract trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01045733, the US trial registry maintained by the National Library of Medicine. NCT01045733 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.